Page last updated: 2024-10-31

nafamostat and Injuries

nafamostat has been researched along with Injuries in 4 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.

Research Excerpts

ExcerptRelevanceReference
"The systemic effects of epidermal growth factor (EGF) ointment containing nafamostat (NM), gabexate, or gelatin was studied in rats with burns or open wounds."7.68Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open wounds. ( Fuwa, T; Iwakawa, S; Kiyohara, Y; Komada, F; Okumura, K, 1993)
"The systemic effects of epidermal growth factor (EGF) ointment containing nafamostat (NM), gabexate, or gelatin was studied in rats with burns or open wounds."3.68Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open wounds. ( Fuwa, T; Iwakawa, S; Kiyohara, Y; Komada, F; Okumura, K, 1993)
"Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions."2.53[Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016)
"Nafamostat was more efficient than gabexate or gelatin on wound healing."1.28Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF. ( Fuwa, T; Hirai, M; Iwakawa, S; Kiyohara, Y; Komada, F; Okumura, K, 1990)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yahata, M1
Sakamoto, Y1
Shi, HP1
Wen, Y1
Zhang, C1
Xue, Q1
Lei, ST1
Kiyohara, Y2
Komada, F2
Iwakawa, S2
Fuwa, T2
Okumura, K2
Hirai, M1

Reviews

1 review available for nafamostat and Injuries

ArticleYear
[Anti DIC therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 2016, Volume: 74, Issue:2

    Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa

2016

Other Studies

3 other studies available for nafamostat and Injuries

ArticleYear
[Role of pancreatic enzymes in gut injury secondary to trauma/hemorrhagic shock in rats].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:10

    Topics: Animals; Benzamidines; Guanidines; Intestines; Male; Pancreas; Rats; Rats, Sprague-Dawley; Shock, He

2004
Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open wounds.
    Biological & pharmaceutical bulletin, 1993, Volume: 16, Issue:1

    Topics: Animals; Aspartate Aminotransferases; Benzamidines; Body Weight; Burns; Drug Interactions; Drug Syne

1993
Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF.
    Pharmaceutical research, 1990, Volume: 7, Issue:12

    Topics: Animals; Benzamidines; Biotransformation; Dose-Response Relationship, Drug; Drug Combinations; Drug

1990